News tagged with gemcitabine
Related topics: pancreatic cancer
Less-toxic chemo improves outlook for advanced bladder cancer
(Medical Xpress) -- New data from the University of Rochester Medical Center confirms that an easier, two-drug chemotherapy regimen given to bladder cancer patients prior to surgery shrinks locally advanced tumors and completely ...
Aug 19, 2011 |
not rated yet |
0
Blood proteins may identify vulnerability of pancreatic cancers to avastin
(Medical Xpress) -- Tiny tumor proteins circulating in blood may be used to identify which pancreatic cancer patients would benefit from the drug Avastin, researchers at Duke University Medical Center have found.
Jun 07, 2011 |
not rated yet |
0
GOLFIG increased progression-free survival in colorectal cancer patients
Oncologists can use colorectal cancer patients' own immune system to boost the effects of chemotherapy and increase progression-free survival, according to Phase III study results presented at the AACR 102nd Annual Meeting ...
Apr 06, 2011 |
not rated yet |
0
Erlotinib improves progression-free survival as first-line therapy in advanced lung cancer
For patients with advanced lung cancer whose tumors carry EGFR activating mutations, first-line treatment with erlotinib nearly tripled progression-free survival compared to a standard chemotherapy combination, show results ...
Oct 09, 2010 |
not rated yet |
0
Lung cancer survival rates improved through use of individualized chemotherapy
Chemotherapy is the best broad defense against cancer recurrence after surgical resection. However, it is difficult to predict which patients will benefit from which regimen of anticancer drugs, if at all. Building on existing ...
Sep 01, 2010 |
not rated yet |
0
Response to preoperative therapy may predict survival in pancreatic cancer patients
Cancer of the pancreas--a glandular organ that lies behind the stomach and secretes vital enzymes and hormones--seldom is detected in early stages, making treatment difficult and survival statistics particularly grim. However, ...
May 31, 2010 |
5 / 5 (1) |
0
Best care for the oldest lung cancer patients
Although more than two fifths of lung cancers are diagnosed in patients over 70, data from clinical trials on the safest and most effective treatments for this age group are scarce. Now Italian oncologists are conducting ...
Apr 29, 2010 |
not rated yet |
0
Researchers find new chemotherapy combination shows promise in endometrial cancer
Researchers from The University of Texas M. D. Anderson Cancer Center report that in a small study of women with advanced or recurrent endometrial cancer, gemcitabine and cisplatin, when used in combination, produced a response ...
Mar 17, 2010 |
5 / 5 (1) |
0
Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy
For the first time researchers have shown that by inhibiting the action of an enzyme called TAK-1, it is possible to make pancreatic cancer cells sensitive to chemotherapy, opening the way for the development of a new drug ...
Sep 24, 2009 |
4 / 5 (1) |
0
Gene assay to help to predict lung cancer treatment resistance
The genes that may contribute to drug resistance in non-small cell lung cancer (NSCLC) can be predicted. Researchers writing in the open access journal BMC Cancer found good correlation between genes believed to be involv ...
Aug 26, 2009 |
5 / 5 (1) |
0
New drug candidate prolongs the lives of pancreatic cancer patients
Every year, 42,000 Americans are diagnosed with pancreatic cancer. Few live very long, and less than 5% are still alive five years after diagnosis.
Jul 20, 2009 |
not rated yet |
1
Researchers identify critical marker of response to gemcitabine in pancreatic cancer
A protein related to aggressive cancers can actually improve the efficacy of gemcitabine at treating pancreatic cancer, according to a Priority Report in Cancer Research, published by researchers at Thomas Jefferson Univer ...
Jun 04, 2009 |
3 / 5 (1) |
0
Experimental insulin-like growth factor receptor inhibitor reduced pancreatic cancer growth
Researchers at Amgen are testing a fully human monoclonal antibody that inhibits the activity of insulin-like growth factors (IGF-1 and IGF-2) and appears to reduce pancreatic cancer cells in early testing, according to a ...
Apr 14, 2009 |
not rated yet |
0
Glitches in DNA repair genes predict prognosis in pancreatic cancer
Variations in mismatch repair genes can help predict treatment response and prognosis in patients with pancreatic cancer, according to research from The University of Texas M. D. Anderson Cancer Center presented today in ...
Jan 14, 2009 |
5 / 5 (1) |
0
